MUSSINI, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 43.684
EU - Europa 21.644
AS - Asia 7.676
AF - Africa 171
SA - Sud America 154
OC - Oceania 58
Continente sconosciuto - Info sul continente non disponibili 31
Totale 73.418
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 43.398
GB - Regno Unito 7.657
IT - Italia 6.184
SG - Singapore 2.359
SE - Svezia 2.173
CN - Cina 2.139
DE - Germania 1.626
HK - Hong Kong 1.392
FI - Finlandia 726
UA - Ucraina 649
FR - Francia 618
ID - Indonesia 543
TR - Turchia 497
BG - Bulgaria 487
RU - Federazione Russa 267
CA - Canada 249
NL - Olanda 214
IN - India 208
IE - Irlanda 148
SI - Slovenia 134
LT - Lituania 118
ES - Italia 116
IR - Iran 115
BE - Belgio 113
VN - Vietnam 101
CH - Svizzera 89
MY - Malesia 76
RO - Romania 75
ZA - Sudafrica 75
CZ - Repubblica Ceca 66
BR - Brasile 62
JP - Giappone 58
AU - Australia 49
PL - Polonia 36
KR - Corea 33
CL - Cile 29
AR - Argentina 24
EU - Europa 24
GR - Grecia 24
PK - Pakistan 24
UG - Uganda 23
CO - Colombia 22
NO - Norvegia 22
AE - Emirati Arabi Uniti 21
BZ - Belize 20
EG - Egitto 19
PH - Filippine 19
RS - Serbia 19
SA - Arabia Saudita 14
TH - Thailandia 14
IL - Israele 13
MK - Macedonia 13
DK - Danimarca 10
TZ - Tanzania 10
BD - Bangladesh 9
MX - Messico 9
NZ - Nuova Zelanda 9
PT - Portogallo 9
AT - Austria 8
ET - Etiopia 8
IQ - Iraq 8
A2 - ???statistics.table.value.countryCode.A2??? 7
EC - Ecuador 7
HR - Croazia 6
HU - Ungheria 6
LK - Sri Lanka 6
LV - Lettonia 6
PE - Perù 6
SK - Slovacchia (Repubblica Slovacca) 6
TW - Taiwan 6
BO - Bolivia 4
KE - Kenya 4
KG - Kirghizistan 4
LS - Lesotho 4
PA - Panama 4
ZM - Zambia 4
AL - Albania 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BW - Botswana 3
EE - Estonia 3
KZ - Kazakistan 3
MD - Moldavia 3
NG - Nigeria 3
SD - Sudan 3
BY - Bielorussia 2
DZ - Algeria 2
GH - Ghana 2
KH - Cambogia 2
MA - Marocco 2
MC - Monaco 2
MG - Madagascar 2
NI - Nicaragua 2
PR - Porto Rico 2
ZW - Zimbabwe 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
CI - Costa d'Avorio 1
CM - Camerun 1
CY - Cipro 1
Totale 73.406
Salva come PNG Salva come JPEG
Città #
Southend 6.586
Fairfield 6.140
Santa Clara 5.627
Ashburn 3.405
Woodbridge 3.404
Chandler 3.320
Houston 2.623
Seattle 2.342
Cambridge 2.064
Wilmington 2.019
Singapore 1.958
Nyköping 1.527
Hong Kong 1.368
Ann Arbor 1.338
Jacksonville 1.286
Dearborn 1.228
Modena 850
San Diego 735
Beijing 595
Princeton 547
Jakarta 533
Helsinki 513
New York 501
Sofia 478
Milan 407
Rome 375
London 331
Izmir 324
Eugene 276
Bologna 269
Bremen 260
Shanghai 219
Munich 191
Redwood City 186
Boardman 148
Fremont 140
Dublin 131
Des Moines 117
Moscow 114
Brussels 103
Toronto 100
Falls Church 96
Naples 94
Parma 93
Dong Ket 89
Frankfurt am Main 88
Amsterdam 84
Florence 83
Norwalk 83
Los Angeles 76
Paris 71
San Jose 67
Nanjing 63
Kilburn 61
Madrid 57
Turin 53
Guangzhou 52
Chicago 51
Grafing 49
Reggio Emilia 49
Hounslow 48
Ottawa 47
Palermo 47
Brno 46
Hefei 46
Chiswick 45
Catania 44
Phoenix 43
Buffalo 42
Washington 41
Kunming 40
Genoa 39
Verona 39
Bari 38
Leawood 38
Dallas 37
Las Vegas 37
North York 37
Wuhan 36
Padova 35
Perugia 35
Roncoferraro 35
Brescia 34
Prescot 34
Rimini 33
Zurich 33
Piacenza 32
Tokyo 32
Lappeenranta 30
San Mateo 30
Augusta 28
Berlin 28
Jinan 27
Mumbai 26
Reggio Nell'emilia 26
Bucharest 24
Bergamo 23
Nanchang 21
Belize City 20
Pescara 20
Totale 57.433
Salva come PNG Salva come JPEG
Nome #
Un raro caso di prostatite da Candida albicans, Candida krusei ed Enterococcus fecium 1.177
Late presentation increases risk and costs of non-infectious comorbidities in people with HIV: An Italian cost impact study 724
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays 689
Comparative evaluation of subtyping tools for surveillance of newly emerging HIV-1 strains 633
Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease 566
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 535
Migration and health: A retrospective study about the prevalence of HBV, HIV, HCV, tuberculosis and syphilis infections amongst newly arrived migrants screened at the Infectious Diseases Unit of Modena, Italy 496
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 390
Granulicatella adiacens and Abiotrophia defectiva Native Vertebral Osteomyelitis: Three Cases and Literature Review of Clinical Characteristics and Treatment Approach 359
Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation 331
Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study 329
A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severity 323
Acinetobacter baumannii Resistance to Sulbactam/Durlobactam: A Systematic Review 307
T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy. 298
Gastric Mucormycosis in a Liver and Kidney Transplant Recipient: Case Report and Concise Review of Literature 282
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 282
Successful treatment of HIV-1 infection increases the expression of a novel, short transcript for IL-18 receptor α chain 277
A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit 276
Analysis of inflammasomes and antiviral sensing components reveals decreased expression of NLRX1 in HIV-positive patients assuming efficient antiretroviral therapy 274
Handling and processing of blood specimens from patients with Covid-19 for safe studies on cell phenotype and cytokine storm 272
Clinical outcome of kidney transplantation in HIV-infected recipients: a retrospective study 269
Aging with HIV infection: a journey to the center of inflammAIDS, immunosenescence and neuroHIV 261
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 259
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 255
Exploring viral reservoir: The combining approach of cell sorting and droplet digital PCR 255
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 254
The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans 250
T cell homeostasis in centenarians: from the thymus to the periphery. 247
Th1 and Th17 pro-inflammatory profile characterizes iNKT cells in virologically suppressed HIV+ patients with low CD4/CD8 ratio 245
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study 243
A frailty index predicts post-liver transplant morbidity and mortality in HIV-positive patients 240
Rhodococcus equi Pneumonia in Kidney Transplant Recipient Affected by Acute Intermittent Porphyria: A Case Report 240
Ageing and inflammation in patients with HIV infection 237
Aging with HIV vs. HIV Seroconversion at Older Age: A Diverse Population with Distinct Comorbidity Profiles 234
Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome 230
Increased plasma levels of extracellular mitochondrial DNA during HIV infection: a new role for mitochondrial damage-associated molecular patterns during inflammation. 229
Impact of polypharmacy on antiretroviral prescription in people living with HIV. 227
Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors 225
Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia 225
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. 224
Cytometry, immunology, and HIV infection: Three decades of strong interactions. 223
HIV-1 Infection and the Aging of the Immune System: Facts, Similarities and Perspectives 221
Mitochondrial DNA Haplogroups and Highly Active Antiretroviral Therapy–Related Lipodystrophy 218
The protease inhibitor atazanavir triggers autophagy and mitophagy in human preadipocytes 218
Immunophenotypic Profile and Clinical Outcome of Monoclonal B-cell Lymphocytosis in Kidney Transplantation 218
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 218
Mucorales-specific T cells in patients with hematologic malignancies 216
Impact of Pre-Analytical Time on the Recovery of Pathogens from Blood Cultures: Results from a Large Retrospective Survey 215
Absence of liver steatosis in HIV-HCV co-infected patients receiving regimens containing tenofovir or abacavir 214
Gram-positive bloodstream infections in liver transplant recipients: incidence, risk factors, and impact on survival. 214
Correlates of frailty phenotype and frailty index and their associations with clinical outcomes 214
Novel genetic association of TNF-α-238 and PDCD1-7209 polymorphisms with long-term non-progressive HIV-1 infection. 212
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 212
Lower Frailty Is Associated with Successful Cognitive Aging Among Older Adults with HIV 212
CD4+ T-cell differentiation, regulatory T cells and gag-specific T lymphocytes are unaffected by CD4-guided treatment interruption and therapy resumption. 212
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 212
Intact parathyroid hormone levels are associated with increased carotid intima media thickness in HIV infected patients 211
Cytotoxic granule release dominates gag-specific CD4+ T-cell response in different phases of HIV infection. 211
Acute human herpes virus 7 (HHV-7) encephalitis in an immunocompetent adult patient: a case report and review of literature 210
Upregulation of nuclear-encoded mitochondrial LON protease in HAART-treated HIV-positive patients with lipodystrophy: implications for the pathogenesis of the disease 209
Decreased mitochondrial DNA content in subcutaneous fat from HIV-infected women taking antiretroviral therapy as measured at delivery. 208
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 208
Apoptotic features of peripheral blood granulocytes and monocytes during primary, acute HIV infection. 207
Tenofovir accelerates bone mass loss of the lumbar spine in the first years of menopause in HIV infected women 207
The natural history of HIV-associated lipodystrophy in the changing scenario of HIV infection 206
HIV-DNA content in different CD4+ T-cell subsets correlates with CD4+ cell : CD8+ cell ratio or length of efficient treatment 206
Reliable and Accurate CD4+ T Cell Count and Percent by the Portable Flow Cytometer CyFlow MiniPOC and “CD4 Easy Count Kit-Dry”, as Revealed by the Comparison with the Gold Standard Dual Platform Technology 206
Changes in central adipose tissue after switching to integrase inhibitors 205
Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14 201
Decay pattern of anti–SARS–CoV–2 antibodies in PWH 200
Clinical and Microbiological Characteristics of Visceral Leishmaniasis Outbreak in a Northern Italian Nonendemic Area: A Retrospective Observational Study 200
Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital 198
NK-cell phenotype at interruption underlies widely divergent duration of CD4+-guided antiretroviral treatment interruption. 198
Stable changes in CD4+ T lymphocyte miRNA expression after exposure to HIV-1. 197
Predictive Value of Intracellular HIV-1 DNA Levels During CD4-Guided Treatment Interruption in HIV(+) Patients 196
Optimization strategies for HIV, hepatitis and syphilis testing in Infectious Disease Clinic and Dermatology Unit of Modena: 7-year results of collaboration experience 196
Identification and characterization of an aspartyl protease from Cryptococcus neoformans 195
Compression of frailty in adults living with HIV 194
Late presenters in an HIV surveillance system in Italy during the period 1992-2006. 193
MMP-7 promoter polymorphisms do not influence CD4+ recovery and changes in plasma viral load during antiretroviral therapy for HIV-1 infection. 193
Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: a Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians 192
Ceftolozane/tazobactam for the treatment of serious P. aeruginosa infections: a multicenter nationwide clinical experience 192
Incidence of HCV infection amongst HIV positive men who had sex with men and prevalence data from patients followed at the Infectious Diseases Clinic of Modena, Italy 192
Molecular Imaging of Vascular Calcification with 18 F-Sodium-Fluoride in Patients Infected with Human Immunodeficiency Virus 192
Liver steatosis and non-alcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV 192
Mitochondrial DNA: a proinflammatory 'enemy from within' during HIV infection? 191
Mitochondrial functionality and mitochondrial DNA content in lymphocytes of vertically infected human immunodeficiency virus-positive children with highly active antiretroviral therapy-related lipodystrophy. 191
Massive activation of immune cells with an intact T cell repertoire in acute human immunodeficiency virus syndrome 190
Mitochondrial DNA haplogroups and incidence of lipodystrophy in HIV-infected patients on long-term antiretroviral therapy. 190
Aseptic Osteonecrosis: A Newly Diagnosed Complication in HIV-Infected Patients Undergoing Liver Transplantation. 190
Congenital pyelectasis in children born from mothers on tenofovir containing therapy during pregnancy: report of two cases. 189
Altered Expression of PYCARD, Interleukin 1β, Interleukin 18, and NAIP in Successfully Treated HIV-Positive Patients With a Low Ratio of CD4+ to CD8+ T Cells 189
Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia 189
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 189
HIV patients undergoing second generation antipsychotics show high cardiovascular disease burden 187
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study. 187
The dynamic association between Frailty, CD4 and CD4/CD8 ratio in people aging with HIV 187
Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study 186
Markers of cell death-activation in lymphocytes of vertically HIV-infected children naive to highly active antiretroviral therapy: the role of age. 186
Prediction of hard cardiovascular events in HIV patients 186
Totale 25.760
Salva come PNG Salva come JPEG
Categoria #
all - tutte 368.067
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 368.067
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.379 0 0 0 0 0 1.706 1.728 1.232 1.119 476 697 421
2020/202114.907 1.018 615 988 1.320 2.099 1.795 1.340 1.557 865 1.343 1.171 796
2021/202210.634 777 1.030 792 554 405 713 642 588 1.211 850 1.800 1.272
2022/202310.959 1.236 1.234 906 965 1.235 1.341 331 1.062 1.203 222 573 651
2023/20248.748 363 588 619 844 1.450 790 703 1.129 330 282 531 1.119
2024/202510.505 804 410 453 1.816 4.071 2.951 0 0 0 0 0 0
Totale 74.410